deltatrials
Completed OBSERVATIONAL NCT04037332

Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda (Caramal DRM)

Monitoring of Molecular Markers of Artemisinin Resistance in Plasmodium Falciparum Malaria: Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

Sponsor: Akena Associates Ltd.

Conditions Severe Malaria
Interventions Blood sample (combined with malaria RDT) followed by gentoyping analysis
Updated 8 times since 2019 Last updated: Jan 28, 2021 Started: Jul 27, 2018 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Severe Malaria, this trial is completed. The trial is conducted by Akena Associates Ltd. and has accumulated 8 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Aug 2019 – ~Nov 2020 · 15 months · monthly snapshotSuspended~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotSuspended~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotSuspended~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Dec 2021 — Jul 2024 [monthly]

    Completed

  5. Feb 2021 — Dec 2021 [monthly]

    Completed

    Status: Suspended → Completed

▶ Show 3 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Suspended

  2. Nov 2020 — Jan 2021 [monthly]

    Suspended

  3. Aug 2019 — Nov 2020 [monthly]

    Suspended

    First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Akena Associates Ltd.
  • Clinton Health Access Initiative, Nigeria
  • Kinshasa School of Public Health
  • Makerere University
  • Swiss Tropical & Public Health Institute
Data source: Swiss Tropical & Public Health Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations